Economic burden of resected squamous cell carcinoma of the head and neck in an incident cohort of patients in the UK
SCCHN is the sixth most common cancer worldwide. Locally advanced SCCHN continues to be a therapeutic challenge with high rates of morbidity and mortality and a low cure rate. Despite the apparent impact of SC...